Swiv

Anti-Cancer Drugs - Current Table Of Contents

Anti-Cancer Drugs - April 2009 , Volume 20 , Issue 4

http://www.anti-cancerdrugs.com/pt/re/anticd/toccurrentrss.xml
http://swiv.eu/anti-cancer-drugs-current-table-of-content_156.xml feed
Add to your feed

Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer. Quick resume for : Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.

Page: 217 DOI: 10.1097/CAD.0b013e3283293fd4 Authors: Aprile, Giuseppe; Mazzer, Micol; Moroso, Stefano; Puglisi, Fabio

Normal-like breast cells, but not breast cancer cells, recovered from treatment with N',N''-diethylnorspermine. Quick resume for : Normal-like breast cells, but not breast cancer cells, recovered from treatment with N',N''-diethylnorspermine.

Page: 230 DOI: 10.1097/CAD.0b013e328323fc98 Authors: Myhre, Louise a; Alm, Kersti a; Johansson, Maria C. b; Oredsson, Stina M. a

Resorufin: a lead for a new protein kinase CK2 inhibitor. Quick resume for : Resorufin: a lead for a new protein kinase CK2 inhibitor.

Page: 238 DOI: 10.1097/CAD.0b013e328326472e Authors: Sandholt, Iben Skjoth; Olsen, Birgitte Brinkmann; Guerra, Barbara; Issinger, Olaf-Georg

Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Quick resume for : Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.

Page: 249 DOI: 10.1097/CAD.0b013e328327d476 Authors: Tang, Cong a b; Lu, Yun-Hua a b; Xie, Jing-Hang a b; Wang, Fen a b; Zou, Jia-Ning a b; Yang, Jia-Sen a b; Xing, Ying-Ying a b; Xi, Tao a b

Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001. Quick resume for : Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001.

Page: 259 DOI: 10.1097/CAD.0b013e328328d18b Authors: Baumann, Philipp; Hagemeier, Hilke; Mandl-Weber, Sonja; Franke, Daniel; Schmidmaier, Ralf

Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure. Quick resume for : Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposure.

Page: 267 DOI: 10.1097/CAD.0b013e328329977f Authors: Miettinen, Susanna a b; Grenman, Seija d; Ylikomi, Timo a c

Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients. Quick resume for : Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients.

Page: 277 DOI: 10.1097/CAD.0b013e328329a293 Authors: Di Lorenzo, Giuseppe a; Carteni, Giacomo b; Autorino, Riccardo c; Gonnella, Antonio a; Perdona, Sisto d; Ferro, Matteo e; Longo, Nicola e; Rescigno, Pasquale a; Doria, Francesca a; Faiella, Adriana a; Altieri, Vincenzo e; Palmieri, Giovannella a; Imbimbo, Ciro e; Mirone, Vincenzo e; De Placido, Sabino a

A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer. Quick resume for : A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.

Page: 281 DOI: 10.1097/CAD.0b013e328324bbc1 Authors: Zhao, Jian Guo a; Qiu, Feng b; Xiong, Jian Ping b; Zhang, Ling b; Xiang, Xiao Jun b; Yu, Feng b; Yan, Jun b; Zhan, Zhen Yu b; Feng, Miao b

Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. Quick resume for : Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.

Page: 287 DOI: 10.1097/CAD.0b013e3283273509 Authors: Cao, Weiguo a; Yang, Weiping b; Lou, Guying a; Jiang, Jinsong a; Geng, Mei a; Xi, Wenqi a; Li, Hao a; Ma, Tao b; Jin, Yening a

Gemcitabine, irinotecan and celecoxib in patients with biliary cancer. Quick resume for : Gemcitabine, irinotecan and celecoxib in patients with biliary cancer.

Page: 294 DOI: 10.1097/CAD.0b013e3283287ca0 Authors: Watkins, James F. b; Mayo, Matthew S. a; Smith, Holly J. a c; Williamson, Stephen K. b

Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer. Quick resume for : Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer.

Page: 301 DOI: 10.1097/CAD.0b013e328329707c Authors: Raj, Kavitha P.; Sanati, Homayoon; Mehta, Rita S.; Zell, Jason A.

Bleomycin treatment of brain tumors: an evaluation. Quick resume for : Bleomycin treatment of brain tumors: an evaluation.

Page: 157 DOI: 10.1097/CAD.0b013e328325465e Authors: Linnert, Mette; Gehl, Julie

Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial. Quick resume for : Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.

Page: 165 DOI: 10.1097/CAD.0b013e32831f8ec9 Authors: Wolff, Kerstin a; Wein, Axel a; Reulbach, Udo b; Mannlein, Gudrun a; Bruckl, Valeska a; Meier, Cornelia a; Ostermeier, Nicola a; Schwab, Siegfried A. c; Horbach, Thomas d; Hohenberger, Werner d; Hahn, Eckhart G. a; Boxberger, Frank a

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study. Quick resume for : A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.

Page: 179 DOI: 10.1097/CAD.0b013e328325a867 Authors: Lara, Primo N. Jr a b; Longmate, Jeff c; Evans, Christopher P. a; Quinn, David I. d; Twardowski, Przemyslaw c; Chatta, Gurkamal e; Posadas, Edwin f; Stadler, Walter f; Gandara, David R. a

A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer. Quick resume for : A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.

Page: 185 DOI: 10.1097/CAD.0b013e328325a9d7 Authors: Ferrari, Daris a; Fiore, Jessica a; Codeca, Carla a; Di Maria, Giuseppe a; Bozzoni, Samuela a; Bordin, Veronica a; Caldiera, Sarah a; Luciani, Andrea a; Zonato, Sabrina a; Floriani, Irene b; Foa, Paolo a

Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features. Quick resume for : Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.

Page: 197 DOI: 10.1097/CAD.0b013e3283264719 Authors: Balduzzi, Alessandra a; Montagna, Emilia a; Bagnardi, Vincenzo b g; Torrisi, Rosalba a; Bertolini, Francesco c; Mancuso, Patrizia c; Scarano, Eloise f; Viale, Giuseppe d; Veronesi, Paolo e; Cardillo, Anna a; Orlando, Laura a; Goldhirsch, Aron f; Colleoni, Marco a

Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results. Quick resume for : Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.

Page: 204 DOI: 10.1097/CAD.0b013e328327d492 Authors: Michalaki, Vasiliki; Gennatas, Spyridon; Gennatas, Konstantine

Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer. Quick resume for : Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer.

Page: 215 DOI: 10.1097/CAD.0b013e3283163c26 Authors: Turner, Jeffrey a; Chaudhary, Uzair b

Association of a single nucleotide polymorphic variation in the human chromosome 19q13.3 with drug responses in the NCI60 cell lines. Quick resume for : Association of a single nucleotide polymorphic variation in the human chromosome 19q13.3 with drug responses in the NCI60 cell lines.

Page: 174 DOI: 10.1097/CAD.0b013e3283229ae3 Authors: Nissen, Kari K. a; Vogel, Ulla b; Nexo, Bjorn A. a

Phase II study of capecitabine plus cisplatin in patients with gastric cancer. Quick resume for : Phase II study of capecitabine plus cisplatin in patients with gastric cancer.

Page: 191 DOI: 10.1097/CAD.0b013e328325a9ec Authors: Salah-Eldin, Manal A. a; Ebrahim, Mohamed A. a; AL-Ashry, Mohamed S. b

GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Quick resume for : GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.

Page: 208 DOI: 10.1097/CAD.0b013e328322fbaa Authors: Zhang, Ye a; Qu, Xiujuan a; Jing, Wei a; Hu, Xuejun b; Yang, Xianghong c; Hou, Kezuo a; Teng, Yuee a; Zhang, Jingdong a; Liu, Yunpeng a

Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054. Quick resume for : Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054.

Page: 83 DOI: 10.1097/CAD.0b013e328320791c Authors: Growcott, James W.

Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. Quick resume for : Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer.

Page: 89 DOI: 10.1097/CAD.0b013e3283222c12 Authors: Aaron DuVall, G. a; Tarabar, Dino c; Seidel, Richard H. a; Elstad, Nancy L. b; Fowers, Kirk D. b

Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study. Quick resume for : Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study.

Page: 97 DOI: 10.1097/CAD.0b013e328322fbc5 Authors: Lentz, Frederike a; Drescher, Anne a; Lindauer, Andreas a; Henke, Magdalena b; Hilger, Ralf A. b; Hartinger, Christian G. c; Scheulen, Max E. b; Dittrich, Christian d; Keppler, Bernhard K. c; Jaehde, Ulrich a; in collaboration with Central European Society for Anticancer Drug Research-EWIV

Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience. Quick resume for : Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.

Page: 105 DOI: 10.1097/CAD.0b013e32831cdb51 Authors: Mir, Olivier; Alexandre, Jerome; Ropert, Stanislas; Montheil, Vincent; Martin, Idalie; Durand, Jean-Philippe; Goldwasser, Francois

Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity. Quick resume for : Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity.

Page: 109 DOI: 10.1097/CAD.0b013e32831bc09b Authors: Nistico, Cecilia a; Bria, Emilio a; Vaccaro, Vanja a; Cuppone, Federica a; Fornier, Monica d; Sperduti, Isabella b; Carpino, Armando c; Izzo, Fiorentino a; Tropea, Francesco a; Cognetti, Francesco a; Terzoli, Edmondo a

Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Quick resume for : Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.

Page: 115 DOI: 10.1097/CAD.0b013e32831c14ec Authors: Foroodi, Faryar a; Duivenvoorden, Wilhelmina C. a b; Singh, Gurmit a b

Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines. Quick resume for : Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.

Page: 123 DOI: 10.1097/CAD.0b013e3283218080 Authors: Makiyama, Akitaka a; Qin, Baoli a; Uchino, Keita a; Shibata, Yoshihiro a; Arita, Shuji a; Isobe, Taichi a; Hirano, Gen a; Kusaba, Hitoshi a; Baba, Eishi a; Akashi, Koichi a; Nakano, Shuji a b

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Quick resume for : Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.

Page: 131 DOI: 10.1097/CAD.0b013e3283212ade Authors: Chen, Hua a; Sun, Bei a; Pan, Shangha a; Jiang, Hongchi a; Sun, Xueying a b

Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line. Quick resume for : Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line.

Page: 141 DOI: 10.1097/CAD.0b013e32832016a9 Authors: Chen, Ping a; Zhao, Si-Hai b; Chu, Yong-Lie b; Xu, Kun b; Zhu, Li a; Wu, Yuan b; Song, Juan b; Cao, Chun-Xia b; Xue, Xin b; Niu, Yao-Ying a

Selective cytotoxic activity of the marine-derived batzelline compounds against pancreatic cancer cell lines. Quick resume for : Selective cytotoxic activity of the marine-derived batzelline compounds against pancreatic cancer cell lines.

Page: 149 DOI: 10.1097/CAD.0b013e32831fa39e Authors: Guzman, Esther A.; Johnson, Jacob D.; Carrier, Megan K.; Meyer, Cara I.; Pitts, Tara P.; Gunasekera, Sarath P.; Wright, Amy E.

Hypersensitivity reactions to antineoplastic agents: an overview. Quick resume for : Hypersensitivity reactions to antineoplastic agents: an overview.

Page: 1 DOI: 10.1097/CAD.0b013e32831961b3 Authors: Syrigou, Ekaterini a; Makrilia, Nektaria a; Koti, Ioanna a; Saif, Muhammad W. b; Syrigos, Kostas N. a b

Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia. Quick resume for : Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.

Page: 7 DOI: 10.1097/CAD.0b013e32831bc086 Authors: Josefine, Palle a; Britt-Marie, Frost a; Curt, Petersson b; Henrik, Hasle c; Marit, Hellebostad e; Jukka, Kanerva f; Kjeld, Schmiegelow d; Gudmar, Lonnerholm a; on behalf of the Nordic Society for Paediatric Haematology and Oncology

Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas. Quick resume for : Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas.

Page: 15 DOI: 10.1097/CAD.0b013e3283198058 Authors: Grenader, Tal a; Goldberg, Anthony a; Hadas-Halperin, Irit b; Gabizon, Alberto a

The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells. Quick resume for : The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.

Page: 21 DOI: 10.1097/CAD.0b013e3283144610 Authors: Huq, Anja a b; Singh, Baljit a b; Meeker, Thea b; Mascarenhas, Desmond a b

Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells. Quick resume for : Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.

Page: 33 DOI: 10.1097/CAD.0b013e328314b5c5 Authors: Somers-Edgar, Tiffany J.; Rosengren, Rhonda J.

Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells. Quick resume for : Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.

Page: 41 DOI: 10.1097/CAD.0b013e328318292c Authors: Liu, Hong; Li, Liang; Li, Xing-Qi; Liu, Xiu-Jun; Zhen, Yong-Su

Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models. Quick resume for : Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.

Page: 51 DOI: 10.1097/CAD.0b013e32831845e1 Authors: Pennanen, Pasi T. a; Sarvilinna, Nanna S. a; Ylikomi, Timo J. a b

PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Quick resume for : PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells.

Page: 59 DOI: 10.1097/CAD.0b013e3283160fd6 Authors: Li, Dan *; Qu, Xiujuan *; Hou, Kezuo; Zhang, Ye; Dong, Qian; Teng, Yuee; Zhang, Jingdong; Liu, Yunpeng

Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice. Quick resume for : Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.

Page: 65 DOI: 10.1097/CAD.0b013e3283182913 Authors: Lin, Ya-Jun; Zhen, Yong-Su

Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma. Quick resume for : Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.

Page: 73 DOI: 10.1097/CAD.0b013e32831b9b0b Authors: Pintoffl, Jan a; Meisinger, Ines a; Mayer, Frank a; Horger, Marius b d; Weyhern, Claus von c; Kanz, Lothar a; Hartmann, Joerg Thomas a d

Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. Quick resume for : Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.

Page: 75 DOI: 10.1097/CAD.0b013e328312659a Authors: Kripp, Melanie a; Strobel, Philipp b; Dinter, Dietmar c; Lukan, Nadine a; Hochhaus, Andreas a; Hofheinz, Ralf-Dieter a

The spectrum of 5-fluorouracil cardiotoxicity. Quick resume for : The spectrum of 5-fluorouracil cardiotoxicity.

Page: 79 DOI: 10.1097/CAD.0b013e3283165f27 Authors: Dalzell, Jonathan R. a; Samuel, Leslie M. b

Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Quick resume for : Hypertension and proteinuria: a class-effect of antiangiogenic therapies.

Page: 81 DOI: 10.1097/CAD.0b013e3283161012 Authors: Launay-Vacher, Vincent; Deray, Gilbert

Agents from amphibians with anticancer properties. Quick resume for : Agents from amphibians with anticancer properties.

Page: 931 DOI: 10.1097/CAD.0b013e3283139100 Authors: Lu, Chuang-Xin; Nan, Ke-Jun; Lei, Yan

From the podium to the patient: bringing the 2008 ASCO meeting to the clinic. Quick resume for : From the podium to the patient: bringing the 2008 ASCO meeting to the clinic.

Page: 941 DOI: 10.1097/CAD.0b013e328317ee58 Authors: Aprile, Giuseppe a; Belvedere, Ornella a b; Puglisi, Fabio a

Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Quick resume for : Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.

Page: 957 DOI: 10.1097/CAD.0b013e328313e15b Authors: Chen, Ming-Hui a; Cui, Shu-Xiang b; Cheng, Yan-Na a; Sun, Li-Rui a; Li, Qian-Bin a; Xu, Wen-Fang a; Ward, Stephen G. c; Tang, Wei a d; Qu, Xian-Jun a

ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells. Quick resume for : ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.

Page: 967 DOI: 10.1097/CAD.0b013e32831087e8 Authors: Sun, Jian a b; Li, Zhi-Ming a b; Hu, Zhe-Yu a b; Lin, Xu-Bin a b; Zhou, Ning-Ning a b; Xian, Li-Jian a b; Yang, Da-Jun c; Jiang, Wen-Qi a b

Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation. Quick resume for : Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation.

Page: 975 DOI: 10.1097/CAD.0b013e3283140c6f Authors: Kwee, Jolie Kiemlian; Luque, Diogo Gomes; Ferreira, Ana Carolina dos Santos; Vasconcelos, Flavia da Cunha; Silva, Karina Lani; Klumb, Claudete Esteves; Maia, Raquel Ciuvalschi

Activity of lipoplatin in tumor and in normal cells in vitro. Quick resume for : Activity of lipoplatin in tumor and in normal cells in vitro.

Page: 983 DOI: 10.1097/CAD.0b013e3283114fb2 Authors: Arienti, Chiara a; Tesei, Anna a; Ravaioli, Alberto b; Ratta, Marina b; Carloni, Silvia a; Mangianti, Serena b; Ulivi, Paola a; Nicoletti, Stefania b; Amadori, Dino a; Zoli, Wainer a

Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts. Quick resume for : Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts.

Page: 991 DOI: 10.1097/CAD.0b013e328313e172 Authors: Labussiere, Marianne a; Aarnink, Alice a; Pinel, Sophie a; Taillandier, Luc a g; Escanye, Jean-Marie b; Barberi-Heyob, Muriel c; Bernier-Chastagner, Valerie d; Plenat, Francois a e; Chastagner, Pascal a f

Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms. Quick resume for : Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.

Page: 999 DOI: 10.1097/CAD.0b013e3283126585 Authors: Reddy, Lakkireddy Harivardhan a; Ferreira, Humberto a; Dubernet, Catherine a; Mouelhi, Sinda Lepetre a; Desmaele, Didier a; Rousseau, Bernard b; Couvreur, Patrick a

Reducing anti-DT IgG concentrations to improve the efficacy of a diphtheria fusion protein. Quick resume for : Reducing anti-DT IgG concentrations to improve the efficacy of a diphtheria fusion protein.

Page: 1007 DOI: 10.1097/CAD.0b013e328310894f Authors: Hall, Philip D. a b; Beagle, Kathryn L. a; Garrett-Mayer, Elizabeth b; Frankel, Arthur E. c

Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer. Quick resume for : Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

Page: 1013 DOI: 10.1097/CAD.0b013e328314b5ab Authors: Zhong, Haijun a; Zhang, Yiping a; Ma, Shenglin a; Ying, Jie-Er a; Yang, Yunshan a; Yong, Dong a; Hang, Xiaosheng b; Sun, Qing c; Zhong, Baoliang e; Wang, Daoyuan d

Targeting the mammalian target of rapamycin in myxoid chondrosarcoma. Quick resume for : Targeting the mammalian target of rapamycin in myxoid chondrosarcoma.

Page: 1019 DOI: 10.1097/CAD.0b013e328312c0e5 Authors: Merimsky, Ofer; Bernstein-Molho, Rinat; Sagi-Eisenberg, Ronit

Anti-Cancer Drugs 2008 Author Index to Volume 19. Quick resume for : Anti-Cancer Drugs 2008 Author Index to Volume 19.

Page: i DOI: 10.1097/01.cad.0000337953.96083.8f

Anti-Cancer Drugs 2008 Keyword Index to Volume 19. Quick resume for : Anti-Cancer Drugs 2008 Keyword Index to Volume 19.

Page: vii DOI: 10.1097/01.cad.0000337954.73212.73

Protein kinase C beta in malignant pleural mesothelioma. Quick resume for : Protein kinase C beta in malignant pleural mesothelioma.

Page: 841 DOI: 10.1097/CAD.0b013e32830ce506 Authors: Faoro, Leonardo a; Loganathan, Sivakumar a; Westerhoff, Maria b; Modi, Rahul a; Husain, Aliya N. b; Tretiakova, Maria b; Seiwert, Tanguy a; Kindler, Hedy L. a; Vokes, Everett E. a; Salgia, Ravi a

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells. Quick resume for : HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.

Page: 849 DOI: 10.1097/CAD.0b013e32830efbeb Authors: Wegener, Dennis a; Deubzer, Hedwig E. a b; Oehme, Ina a; Milde, Till a; Hildmann, Christian c d; Schwienhorst, Andreas c; Witt, Olaf a b

Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma. Quick resume for : Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma.

Page: 859 DOI: 10.1097/CAD.0b013e32830d5887 Authors: Kang, Gyong-Suk b *; Wang, Xiang Di a; Mohler, Michael L. b; Kirichenko, Oleg V. b; Patil, Renukadevi b; Orr, William E. a; Miller, Duane D. b; Geisert, Eldon E. a

Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line. Quick resume for : Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line.

Page: 871 DOI: 10.1097/CAD.0b013e32830f902b Authors: Holst, C. Martina a; Staaf, Johan b; Jonsson, Goran b; Hegardt, Cecilia b; Oredsson, Stina M. a

Impact of naringenin on glycoprotein levels in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Quick resume for : Impact of naringenin on glycoprotein levels in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.

Page: 885 DOI: 10.1097/CAD.0b013e32830ea1bc Authors: Ekambaram, Ganapathy; Rajendran, Peramaiyan; Devaraja, Rajasekaran; Muthuvel, Raju; Sakthisekaran, Dhanapal

In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Quick resume for : In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice.

Page: 891 DOI: 10.1097/CAD.0b013e32830ef8ca Authors: Cui, Wei a; Hu, Shirley X. b; Tang, Zhen-Ya c; Hu, Ke-Qin a

Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status. Quick resume for : Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.

Page: 899 DOI: 10.1097/CAD.0b013e32830f9046 Authors: Desai, Neil P. a; Trieu, Vuong a; Hwang, Larn Yuan a; Wu, Rujin a; Soon-Shiong, Patrick a; Gradishar, William J. b

Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial. Quick resume for : Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.

Page: 911 DOI: 10.1097/CAD.0b013e3283099e71 Authors: Nishimura, Reiki a; Tominaga, Takeshi b; Kimura, Morihiko c; Yanagita, Yasuhiro c; Tamaki, Nobumitsu d; Asaishi, Kazuaki e; Okamoto, Yasushi f; Okuyama, Nobuo g; Takeuchi, Hideki h; Inaba, Masaharu i; Doi, Takako j

Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma. Quick resume for : Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.

Page: 917 DOI: 10.1097/CAD.0b013e32830cebc1 Authors: Villela, Luis a b; Garcia, Mauricio a; Caballero, Rocio a; Borbolla-Escoboza, Jose R. b; Bolanos-Meade, Javier c

A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 alone. Quick resume for : A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 alone.

Page: 921 DOI: 10.1097/CAD.0b013e32830d58a6 Authors: Ishido, Kenji a; Koizumi, Wasaburo a; Tanabe, Satoshi a; Higuchi, Katsuhiko a; Sasaki, Tohru a; Katada, Chikatoshi a; Azuma, Mizutomo a; Saigenji, Katsunori a; Futawatari, Nobue b; Saegusa, Makoto c

Cisplatin-associated thrombosis. Quick resume for : Cisplatin-associated thrombosis.

Page: 927 DOI: 10.1097/CAD.0b013e3283100e9c Authors: Jafri, Mariam; Protheroe, Andrew

Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations? Quick resume for : Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations?

Page: 761 DOI: 10.1097/CAD.0b013e32830b58c4 Authors: Decaudin, Didier a; Dolcetti, Riccardo e; de Cremoux, Patricia b; Ponzoni, Maurilio f g; Vincent-Salomon, Anne b; Doglioni, Claudio f g; Dendale, Remi c; Escande, Marie-Christine b; Rouic, Livia Lumbroso-Le d; Ferreri, Andres J.M. g h

Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Quick resume for : Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells.

Page: 766 DOI: 10.1097/CAD.0b013e32830b5894 Authors: Yeruva, Laxmi; Elegbede, John Abiodun; Carper, Stephen W.

Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells. Quick resume for : Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.

Page: 777 DOI: 10.1097/CAD.0b013e32830c236a Authors: Park, Juwon a; Ahn, Kwang-Sung a; Bae, Eun-Kyung e; Kim, Byung-Su a b; Kim, Byoung Kook a b c; Lee, Young-Yiul a d; Yoon, Sung-Soo a b c

Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells. Quick resume for : Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells.

Page: 783 DOI: 10.1097/CAD.0b013e32830c432d Authors: Gilbert, Jennifer L. a c; Purcell, James a c; Strappe, Padraig c; McCabe, Matthew b; O'Brien, Timothy c; O'Dea, Shirley a c

In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives. Quick resume for : In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives.

Page: 789 DOI: 10.1097/CAD.0b013e32830ce4d8 Authors: Rossignol, Emilie a; Debiton, Eric b; Fabbro, Doriano c; Moreau, Pascale a; Prudhomme, Michelle a; Anizon, Fabrice a

Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Quick resume for : Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells.

Page: 793 DOI: 10.1097/CAD.0b013e32830ce4f5 Authors: Singh, Vivek; Singh, Mahendra Pal; Singh, Sukh Mahendra

9-Nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats. Quick resume for : 9-Nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats.

Page: 805 DOI: 10.1097/CAD.0b013e3283099e5c Authors: Dadashzadeh, Simin a c; Derakhshandeh, Katayoun a d; Shirazi, Farshad Hoseini b c

Sequential effects of daily arsenic trioxide treatment on essential and nonessential trace elements in tissues in mice. Quick resume for : Sequential effects of daily arsenic trioxide treatment on essential and nonessential trace elements in tissues in mice.

Page: 812 DOI: 10.1097/CAD.0b013e32830c456b Authors: Molin, Ylva a; Frisk, Peter b; Ilback, Nils-Gunnar a c

Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase. Quick resume for : Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

Page: 819 DOI: 10.1097/CAD.0b013e3283094b5d Authors: Koizumi, Wasaburo a; Okayasu, Isao b; Hyodo, Ichinosuke c; Sakamoto, Junichi d; Kojima, Hiroshi e; the Clinical Study Group of Capecitabine

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer. Quick resume for : Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

Page: 825 DOI: 10.1097/CAD.0b013e32830c457e Authors: Liu, Chaoying a; Sun, Qing b; Hang, Xiaosheng c; Zhong, Baoliang d; Wang, Daoyuan e

Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Quick resume for : Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.

Page: 832 DOI: 10.1097/CAD.0b013e32830b58b0 Authors: Stemmler, Hans-Joachim a; Mengele, Karin d; Schmitt, Manfred d; Harbeck, Nadia d; Laessig, Dorit a; Herrmann, Karin A. b; Schaffer, Pamela c; Heinemann, Volker a

Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy. Quick resume for : Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.

Page: 837 DOI: 10.1097/CAD.0b013e32830c2380 Authors: Ferrari, Daris a; Di Maria, Giuseppe a; Fazio, Nicola b; Codeca, Carla a; Fiore, Jessica a; Luciani, Andrea a; Oldani, Sabina a; Maggioni, Marco c; Foa, Paolo a

Neurotransmission and cancer: implications for prevention and therapy. Quick resume for : Neurotransmission and cancer: implications for prevention and therapy.

Page: 655 DOI: 10.1097/CAD.0b013e3283025b58 Authors: Schuller, Hildegard M.

Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphoma. Quick resume for : Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphoma.

Page: 673 DOI: 10.1097/CAD.0b013e3283043574 Authors: Decaudin, Didier a d; Dendale, Remi b; Lumbroso-Le Rouic, Livia c

Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells. Quick resume for : Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells.

Page: 681 DOI: 10.1097/CAD.0b013e3283067681 Authors: Roforth, Matthew M. a; Tan, Chalet a b

Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab. Quick resume for : Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab.

Page: 689 DOI: 10.1097/CAD.0b013e3283050083 Authors: Cavalloni, Giuliana a; Sarotto, Ivana b; Pignochino, Ymera a; Gammaitoni, Loretta a; Migliardi, Giorgia a; Sgro, Luca c; Piacibello, Wanda a; Risio, Mauro b; Aglietta, Massimo a; Leone, Francesco a

Two newly synthesized 5-methyltetrahydrofolate-like compounds inhibit methionine synthase activity accompanied by cell cycle arrest in G1/S phase and apoptosis in vitro. Quick resume for : Two newly synthesized 5-methyltetrahydrofolate-like compounds inhibit methionine synthase activity accompanied by cell cycle arrest in G1/S phase and apoptosis in vitro.

Page: 697 DOI: 10.1097/CAD.0b013e32830317f2 Authors: Tang, Cai a; Zhang, Zhili b; Xu, Bo a; Li, Min a; Liu, Junyi b; Cui, Jingrong a

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia. Quick resume for : In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.

Page: 705 DOI: 10.1097/CAD.0b013e328304ae19 Authors: Calabro, Anthony a; Tai, Julia b; Allen, Steven L. a; Budman, Daniel R. a

The differentiation-inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8. Quick resume for : The differentiation-inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8.

Page: 713 DOI: 10.1097/CAD.0b013e3283081ac8 Authors: Zhao, Jing a; Zhao, Yong a; Chen, Wei a; Li, Yi-Min a; Bian, Xiu-Wu b

Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts. Quick resume for : Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts.

Page: 721 DOI: 10.1097/CAD.0b013e328304355f Authors: Staffhorst, Rutger W.H.M. a; van der Born, Kasper b; Erkelens, Caroline A.M. b; Hamelers, Irene H.L. a; Peters, Godefridus J. b; Boven, Epie b; de Kroon, Anton I.P.M. a

Reduced uptake of liposomal idarubicin in the perfused rat heart. Quick resume for : Reduced uptake of liposomal idarubicin in the perfused rat heart.

Page: 729 DOI: 10.1097/CAD.0b013e328304d948 Authors: Sermsappasuk, Pakawadee a; Hrynyk, Rafal b; Gubernator, Jerzy c; Weiss, Michael a

Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer. Quick resume for : Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer.

Page: 733 DOI: 10.1097/CAD.0b013e3283043585 Authors: Rossi, David; Baldelli, Anna Maria; Casadei, Virginia; Fedeli, Stefano Luzi; Alessandroni, Paolo; Catalano, Vincenzo; Giordani, Paolo; Ceccolini, Monica; Graziano, Francesco; Catalano, Giuseppina

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. Quick resume for : A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.

Page: 739 DOI: 10.1097/CAD.0b013e32830676a8 Authors: Caponigro, Francesco a; Romano, Carmen c; Milano, Amalia a; Solla, Raffaele d; Franchin, Giovanni e; Adamo, Vincenzo f; Mari, Ettore g; Morrica, Brunello b; Pepe, Stefano c

Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer. Quick resume for : Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer.

Page: 745 DOI: 10.1097/CAD.0b013e3283067694 Authors: Li, Jin; Yin, Jiliang; Zhu, Xiaodong; Liu, Yanfei; Cao, Junning; Lu, Fangfang; Zuo, Yunxia

Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study. Quick resume for : Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study.

Page: 749 DOI: 10.1097/CAD.0b013e328301c54f Authors: Ramnath, Nithya a; Yu, Jihnhee b; Khushalani, Nikhil I. a; Gottlieb, Ronald H. c; Schwarz, James K. a; Iyer, Renuka V. a; Rustum, Youcef M. d; Creaven, Patrick J. a

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan. Quick resume for : Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Page: 753 DOI: 10.1097/CAD.0b013e328302eb15 Authors: Tokudome, Nahomi a; Ito, Yoshinori a; Hatake, Kiyohiko a; Toi, Masakazu b; Sano, Muneaki c; Iwata, Hiroji d; Sato, Yasuyuki e; Saeki, Toshiaki f; Aogi, Kenjiro f; Takashima, Shigemitsu f

Noscapine induces apoptosis in human glioma cells by an apoptosis-inducing factor-dependent pathway. Quick resume for : Noscapine induces apoptosis in human glioma cells by an apoptosis-inducing factor-dependent pathway.

Page: 553 DOI: 10.1097/CAD.0b013e3282ffd68d Authors: Newcomb, Elizabeth W. a c; Lukyanov, Yevgeniy a *; Smirnova, Iva a *; Schnee, Tona a; Zagzag, David a b c

Purvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase II. Quick resume for : Purvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase II.

Page: 565 DOI: 10.1097/CAD.0b013e3282fe330e Authors: Iizuka, Daisuke; Ogura, Aki; Kuwabara, Mikinori; Inanami, Osamu

Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines. Quick resume for : Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines.

Page: 573 DOI: 10.1097/CAD.0b013e3282fc46b0 Authors: Tong, Qiang-Song a; Jiang, Guo-Song a; Zheng, Li-Duan b; Tang, Shao-Tao a; Cai, Jia-bin a; Liu, Yuan a; Zeng, Fu-Qing a; Dong, Ji-Hua c

Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma. Quick resume for : Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.

Page: 583 DOI: 10.1097/CAD.0b013e3282fb97bf Authors: Gupta, Vivekanand; Singh, Sukh Mahendra

Effect of TM208 on QGY-7703 xenograft tumor growth. Quick resume for : Effect of TM208 on QGY-7703 xenograft tumor growth.

Page: 593 DOI: 10.1097/CAD.0b013e328301390d Authors: Zhang, Ning a; Guo, Wei a; Wang, Li a; Huang, Wei a; Xu, Bo a; Ge, Zemei b; Li, Min a; Li, Run Tao b; Cui, Jing Rong a

Exploiting CD38-mediated endocytosis for immunoliposome internalization. Quick resume for : Exploiting CD38-mediated endocytosis for immunoliposome internalization.

Page: 599 DOI: 10.1097/CAD.0b013e3282ffd673 Authors: Orciani, Monia a; Cavaletti, Guido c; Fino, Vincenzo b; Mattioli-Belmonte, Monica a; Tredici, Giovanni c; Bruni, Paolo b; Di Primio, Roberto a

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Quick resume for : Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Page: 607 DOI: 10.1097/CAD.0b013e32830138f9 Authors: Mearadji, Amir a; den Bakker, Michael A. b; van Geel, Albertus N. a; Eggermont, Alexander M.M. a; Sleijfer, Stefan c; Verweij, Jaap c; de Wilt, Johannes H.W. a; Verhoef, Cornelis a

Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience. Quick resume for : Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.

Page: 613 DOI: 10.1097/CAD.0b013e3283005075 Authors: Scoccianti, Silvia a; Detti, Beatrice a; Sardaro, Angela d; Iannalfi, Alberto a; Meattini, Icro a; Leonulli, Barbara Grilli a; Borghesi, Simona a; Martinelli, Francesco c; Bordi, Lorenzo b; Ammannati, Franco b; Biti, Giampaolo a

The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry. Quick resume for : The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry.

Page: 621 DOI: 10.1097/CAD.0b013e3282ffd6a4 Authors: Brouwers, Elke E.M. a; Huitema, Alwin D.R. a; Schellens, Jan H.M. b c; Beijnen, Jos H. a c

Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma. Quick resume for : Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.

Page: 631 DOI: 10.1097/CAD.0b013e3283017f94 Authors: Lim, Jae Yun a; Jeung, Hei-Cheul a; Mun, Hee Sun a; Lee, Dong Ki b; Paik, Yong Han b; Lee, Se Joon b; Yoon, Dong Sup c; Cho, Jae Yong a

Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies. Quick resume for : Systemic chemotherapy for adrenocortical carcinoma: comparative responses to conventional first-line therapies.

Page: 637 DOI: 10.1097/CAD.0b013e328300542a Authors: Fareau, Gilbert G. a; Lopez, Adriana b; Stava, Charles a; Vassilopoulou-Sellin, Rena a

Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients' survival and quality of life. Quick resume for : Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients' survival and quality of life.

Page: 645 DOI: 10.1097/CAD.0b013e3282ff0f48 Authors: Azim, Hatem A. Jr a; Mok, Tony b

New directions in the management of advanced pancreatic cancer: a review. Quick resume for : New directions in the management of advanced pancreatic cancer: a review.

Page: 435 DOI: 10.1097/CAD.0b013e3282fc9d11 Authors: Rocha-Lima, Caio M.

Capecitabine: an overview of the side effects and their management. Quick resume for : Capecitabine: an overview of the side effects and their management.

Page: 447 DOI: 10.1097/CAD.0b013e3282f945aa Authors: Saif, Muhammad Wasif a; Katirtzoglou, Nikos A. b; Syrigos, Kostas N. a b

Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma. Quick resume for : Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.

Page: 465 DOI: 10.1097/CAD.0b013e3282fc46c4 Authors: Saigal, Babita a; Glisson, Bonnie S. a; Johnson, Faye M. a b

Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling. Quick resume for : Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.

Page: 477 DOI: 10.1097/CAD.0b013e3282fc6cdd Authors: Suwanjunee, Saipin a; Wongchana, Wipawee a; Palaga, Tanapat a b

Nordihydroguaiaretic acid restores expression of silenced E-cadherin gene in human breast cancer cell lines and xenografts. Quick resume for : Nordihydroguaiaretic acid restores expression of silenced E-cadherin gene in human breast cancer cell lines and xenografts.

Page: 487 DOI: 10.1097/CAD.0b013e3282fd5310 Authors: Cui, Yi b c *; Lu, Cailing b c *; Kang, Aijun d; Liu, Liyong e; Tan, Sainan a b c; Sun, Daguang a b c; Hu, Jianguo d; Ma, Xu a b c

Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat. Quick resume for : Hyperbilirubinemia's protective effect against cisplatin nephrotoxicity in the Gunn rat.

Page: 495 DOI: 10.1097/CAD.0b013e3282fdc391 Authors: Barabas, Karri a; Milner, Rowan a; Farese, James a; Baylis, Chris b; Croker, Byron c; Archer, Linda a; Adin, Christopher a

Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis. Quick resume for : Gene induction by glycyrol to apoptosis through endonuclease G in tumor cells and prediction of oncogene function by microarray analysis.

Page: 503 DOI: 10.1097/CAD.0b013e3282fba582 Authors: Lee, SungGa a d; Oh, Hyun-Mee d; Lim, Won-Bong a; Choi, Eun-Ju d; Park, Young-Na d; Kim, Jeong-Ah e; Choi, Ji-Young e; Hong, Suk-Jin c; Oh, Hee-Kyun b; Son, Jong-Keun e; Lee, Seung-Ho e; Kim, Ok-joon a; Choi, Hong-ran a; Jun, Chang-Duk d

Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells. Quick resume for : Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells.

Page: 517 DOI: 10.1097/CAD.0b013e3282faa704 Authors: Soletti, Rossana C. a; de Faria, Giselle Pinto a; Vernal, Javier b; Terenzi, Hernan b; Anderluh, Gregor c; Borges, Helena L. a; Moura-Neto, Vivaldo a *; Gabilan, Nelson H. b *

Interferon-[alpha] in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial. Quick resume for : Interferon-[alpha] in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial.

Page: 527 DOI: 10.1097/CAD.0b013e3282fa4ad2 Authors: Amato, Robert J.; Jac, Jaroslaw; Hernandez-McClain, Joan

Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001 Quick resume for : Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001

Page: 535 DOI: 10.1097/CAD.0b013e3282fb178a Authors: Hejna, Michael a; Raderer, Markus a; Zacherl, Johannes b; Ba-Ssalamah, Ahmed c; Puspok, Andreas d; Schmidinger, Manuela a; Pluschnig, Ursula a; Brodowicz, Thomas a e; Zielinski, Christoph C. a e

Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer. Quick resume for : Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.

Page: 541 DOI: 10.1097/CAD.0b013e3282fcbbf7 Authors: Strauss, Hans-Georg a; Hemsen, Alice a; Karbe, Ina a; Lautenschlager, Christine b; Persing, Monika a; Thomssen, Christoph a

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma. Quick resume for : Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.

Page: 547 DOI: 10.1097/CAD.0b013e3282fc6cf7 Authors: Dawson, Sarah-Jane a *; Conus, Nelly Marmy b *; Toner, Guy C. a d; Raleigh, Jeanette M. b; Hicks, Rodney J. c d; McArthur, Grant a b d; Rischin, Danny a d

Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Quick resume for : Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.

Page: 329 DOI: 10.1097/CAD.0b013e3282f5d4c2 Authors: Rankin, Andrew M. a; Faller, Douglas V. a; Spanjaard, Remco A. b

Neoadjuvant endocrine therapy for breast cancer: past, present and future. Quick resume for : Neoadjuvant endocrine therapy for breast cancer: past, present and future.

Page: 339 DOI: 10.1097/CAD.0b013e3282f97f75 Authors: Barnadas, Agusti a; Gil, Miguel b; Sanchez-Rovira, Pedro c; Llombart, Antonio d; Adrover, Encarna e; Estevez, Laura G. f; de la Haba, Juan g; Calvo, Lourdes h

Swiv Logo Swiv.eu, watch site informative for RSS feed management

RSS (Image)SWIV combines the flow of information to ensure you get a relevant and effective through a personalized RSS feed.

Options
You're SWIV. › Their Satanic Majesties Request
Home
You are not logged.
Login  Create an account
 
Create a feed
Advertisements
RSS feeds
Flows SWIV
 
Enter your info
Create a feed
 
Search
Submit a feed
Thematic flow
 
Form of new flows

If you want to help us build a new RSS feed from existing resources, not the form of an RSS feed published on the Web, you can send us a message. Lay out all the necessary information and your email address, we will keep you informed (e) of the process. Applications clearly out-about will be ignored.

Their Satanic Majesties RequestBad Request for comment Request for Comments Request For Quotation Bad Schandau Bad Segeberg Their satanic Majesties Request RFQ Bad Harzburg RFC
Entry Points
»
Close

Click on the address to select it. Click copy and then paste it into your preferred reader.

Close
Close
Languages
bg cs da de el en es et fi fr gr hu it lt lv mt nl pl pt sk sl sv
Font size
Boxes position
Close
Imprint | Right
© 2006 - 2012 Lexeek, All rights reserved